INS and type 2 diabetes mellitus: It is worth noting that ongoing clinical trials are documenting a significant improvement of glycaemic control in both Type 1 and Type 2 diabetes, in conjunction with smaller postprandial plasma glucose excursions, lower insulin requirements, and weight loss [61].